Home Newsletters Immunology of Infectious Disease News ANP Technologies, Inc. Receives FDA EUA Authorization for its NIDS® COVID-19 Antigen...

ANP Technologies, Inc. Receives FDA EUA Authorization for its NIDS® COVID-19 Antigen Rapid Test Kit

0
ANP Technologies, Inc. announced that it has received Emergency Use Authorization for its NIDS® COVID-19 Antigen Rapid Test Kit from the FDA.
[ANP Technologies, Inc. (BusinessWire, Inc.)]
6445218 {6445218:AAAAAAAA} apa 50 1 167210 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
Press Release
Exit mobile version